Novavax Plunges After FDA Grasp on Flu, Covid Vaccine Paintings
(Bloomberg) — Novavax Inc. stocks fell up to 24% after US regulators positioned a dangle at the corporate’s experimental influenza and Covid-19 aggregate vaccines as a result of a find out about